Mirum Pharmaceuticals Profit Margin

The latest profit margin for MIRM is -187.74% as of June 2026. That compares with -13.65% in the prior-year period — down 1275.8% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Mirum Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, MIRM's profit margin moved from -13.65% to -187.74% — a 1275.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mirum Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, MIRM currently prints -187.74% for profit margin, while the sector average sits near 13.76%. That is roughly 1464.4% below the sector mean. Large gaps often invite a closer look at Mirum Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Mirum Pharmaceuticals converts resources into returns. At -187.74%, MIRM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -13.65% in the prior-year period — down 1275.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MIRM's profit margin (-187.74%), review year-over-year change from -13.65%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.